← FDA DRUG APPROVALS
FDA BLA · BLA761445
SARCLISA ESCENA
isatuximab-irfc
Sponsor: SANOFI-AVENTIS U.S. LLC
APPLICATION
BLA761445
TYPE
BLA
ORIGINAL APPROVAL
2026-07-09
LATEST ACTION
2026-07-09
ROUTE
SUBCUTANEOUS, SINGLE-DOSE
DOSAGE FORM
VIAL
MARKETING STATUS
Prescription
Products
SARCLISA ESCENAPrescription
ISATUXIMAB-IRFC 1400MG/10ML (140MG/ML) · VIAL · SINGLE-DOSE
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.